Highest-materiality recent filing
Broadway Financial corrects Q1 2026 results: net income $1.2M vs year-ago loss
Revised net income before preferred dividends $1.2M ($0.13 diluted EPS), vs net loss $2.7M (-$0.31) in Q1 2025.
Broadway Financial Q1 net income $1.6M vs loss; loans and deposits grow, borrowings eliminated
Net income before preferred dividends $1.6M ($0.09 diluted EPS) vs net loss $2.7M (-$0.39) in Q1 2025, a $4.3M improvement.
City First Bank (BYFC) awarded $75M NMTC allocation from CDFI Fund
Broadway Financial's bank subsidiary receives $75 million New Markets Tax Credit allocation.
Broadway Financial regains compliance with Nasdaq Listing Rule 5250(c)(1)
Received Nasdaq letter on Feb 17, 2026 confirming compliance after filing Form 10-Q for period ended Sep 30, 2025.
Broadway Financial receives Nasdaq non-compliance notice for late Q3 10-Q filing
Received Nasdaq notice on Nov 20, 2025 for failing to timely file Q3 10-Q under Listing Rule 5250(c)(1).
Broadway Financial gets Nasdaq extension to Feb 2026 to file delayed Q2 10-Q
Received Nasdaq extension to February 16, 2026, to regain compliance with Rule 5250(c)(1) by filing Q2 2025 10-Q.
Broadway Financial restates 2023-2024, Q1 2025 results; loan participation accounting errors
Audit committee concludes audited FY 2023/2024 and unaudited Q1-Q3 2024 and Q1 2025 financials are unreliable.
Broadway Financial to record $25.9M goodwill impairment charge for Q3 2025
Audit Committee concluded goodwill is impaired under GAAP after annual impairment analysis.
Broadway Financial receives Nasdaq non-compliance notice for late Q2 2025 10-Q filing
Received Nasdaq notice Aug 21, 2025 for failing to timely file Q2 2025 Form 10-Q.
Broadway Financial Q2 2025: net income before preferred $603K, diluted loss ($0.02) per common share
Q2 net income before preferred dividends $603K vs $269K YoY; net loss attributable to common $147K after $750K preferred dividends.
Broadway Financial revises Q1 2025 results; $1.9M wire fraud loss drives net loss of $1.9M
Net loss of $1.9M ($0.21 diluted EPS) vs. loss of $164K in Q1 2024; net loss attrib. to common $2.6M ($0.30/share).
Broadway Financial corrects 8-K: charter amendment proposal fails at annual meeting
Amendment to 8-K filed July 2 corrects error: charter amendment proposal was not approved.
Broadway Financial reports annual meeting voting results; all proposals approved
Three directors elected: Davidson (2,862,844 for), Driver (2,865,762), Ross (2,869,362).
Broadway Financial director William A. Longbrake to resign at 2025 Annual Meeting
William A. Longbrake notified the Board he is resigning as director effective June 30, 2025.
Broadway Financial receives Nasdaq delisting notice for late Q1 10-Q filing
Nasdaq notified Broadway on May 28, 2025, for non-compliance with Listing Rule 5250(c)(1) due to late Form 10-Q.
On June 2, 2025, William A. Longbrake, a member of the Board of Directors (the “Board”) of Broadway Financial Corporation (the “Company”) (NASDAQ: BYFC), notified the Board that he is resigning as a director of the Company at the Company’s 2025 Annual Meeting of Stockholders on June 30, 2025.
Max materiality 0.90 · Median 0.60 · Most common event other_material